Oncology Institute (TOI) Other Non Operating Income (2020 - 2026)

Oncology Institute has reported Other Non Operating Income for 7 years, with the latest figure at $791000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 123.9% year-over-year to $791000.0; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 293.73% YoY), and the FY2025 full-year result was -$925000.0, down 153.42% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $791000.0, down from $12.3 million in the prior quarter.
• The five-year high for Other Non Operating Income was $24.0 million in Q4 2022, with the low at -$6.0 million in Q3 2025.
• Historically, Other Non Operating Income has averaged $2.9 million across 5 years, with a median of $41500.0 in 2022.
• The largest YoY upside for Other Non Operating Income was 4831.03% in 2025 against a maximum downside of 4966.18% in 2025.
• Oncology Institute's Other Non Operating Income stood at $24.0 million in 2022, then tumbled by 94.87% to $1.2 million in 2023, then sank by 121.19% to -$261000.0 in 2024, then surged by 4831.03% to $12.3 million in 2025, then tumbled by 93.59% to $791000.0 in 2026.
• The last three Other Non Operating Income figures came in at $791000.0 (Q1 2026), $12.3 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.